Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early phase clinical trial that found an ...

In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...

Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce viral levels and may help ...

Since it was first detected in the United States in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human ...

It's been available in the northern hemisphere for years, now Australian children can receive a nasal spray vaccine for the flu.

The experimental nasal vaccine developed at Chiba University stimulated strong and long-lasting immune responses in animal models, activating tumor-fighting cells in the cervix and slowing cervical ...

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide ...

A Johns Hopkins team has developed a nasal spray DNA vaccine aimed at tuberculosis bacteria that persist after lengthy antibiotic treatment. In mice, the vaccine used with standard TB drugs sped ...

A vaccine usually trains your immune system to recognize one target. Here, the target is basically “anything that doesn’t belong in the lungs.” That is the surprising promise behind a new mouse study ...

It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...

A bird flu vaccine that pairs a traditional shot with nasal drops completely shielded young dairy calves and mice from severe ...